Genetic variants linked to a 57% higher risk of heart disease are reshaping modern approaches to preventive care and influencing personalized health strategies.
3X4 Genetics, a global leader in personalized genetic testing, has announced groundbreaking findings from a recent study involving 300,000 UK participants. The research highlights key genetic variants that significantly increase the risk of coronary artery disease (CAD), one of the leading causes of death worldwide.
The study revealed that 2.3% of participants carry markers with a threefold increased CAD risk, while 6.1% have genes linked to atrial fibrillation, a leading cause of stroke. Over 50% of CAD risk is attributed to genetic predisposition.
“These findings underscore the critical role of genetic testing in healthcare,” said Tony Hsu, CEO of 3X4 Genetics. “Understanding genetic predispositions allows us to manage heart health proactively and effectively.”
Dr. Yael Joffe, Founder and Chief Science Officer, added, “This research aligns with our mission to translate complex genetic data into actionable health insights. It’s not just about identifying risk; it’s about empowering individuals to make informed decisions about their health.”
3X4 Genetics’ innovative testing technology goes beyond standard practices and analyzes how multiple genes interact, providing a complete picture of your heart health. This holistic approach enables the delivery of personalized, actionable insights for each individual.
While genetics play a significant role, lifestyle changes remain vital. The study showed that individuals informed about their genetic risks were 30% more likely to adopt healthier habits, significantly lowering their risk of heart disease.
With these powerful genetic insights and lifestyle modifications, 3X4 Genetics aims to enhance long-term health outcomes.
3X4 Genetics incorporates these findings into its comprehensive genetic panels, providing personalized diet, lifestyle, and supplement recommendations. This approach empowers individuals to make informed decisions tailored to their unique genetic makeup. Upcoming initiatives include expanding its testing panels to include more comprehensive cardiovascular risk markers, further enhancing its offerings.
Najwa, a 3X4 Genetics customer, shares her experience: “Genetic testing transformed my approach to heart health. With personalized insights, I was able to address specific genetic factors impacting my cardiovascular health.”
3X4 Genetics is not just predicting the future of healthcare; it’s actively shaping it by bridging the gap between genetic science and everyday health decisions, empowering individuals to take charge of their heart health.
For more information, contact Honey Bhargava at honey@boringmarketing.com.
About 3X4 Genetics
3X4 Genetics is a leader in personalized genetic testing, offering cutting-edge health solutions that empower individuals to make informed decisions about their health. Specializing in cardiovascular health, 3X4 Genetics combines the latest genetic insights with practical lifestyle recommendations to help individuals take charge of their well-being. Headquartered in Bellevue, WA, the company is committed to advancing preventive healthcare. For more information, visit 3X4 Genetics.
Media Contact:
Company Name: 3X4 Genetics
Contact Person: Honey Bhargava
Email: honey@boringmarketing.com
Website: https://3x4genetics.com
City: Seattle
State: Washington State
Country: USA
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Times World USA journalist was involved in the writing and production of this article.
